Eosinophilic fasciitis and lichen sclerosus in a patient treated with nivolumab

Australas J Dermatol. 2018 Nov;59(4):e302-e304. doi: 10.1111/ajd.12836. Epub 2018 May 24.

Authors

Juan-José Andrés-Lencina¹, Sara Burillo-Martínez¹, Raquel Aragón-Miguel¹, Alba Calleja-Algarra¹, José-Luis Rodríguez-Peralto², Pablo-Luis Ortiz-Romero¹, Vanessa Gargallo-Moneva¹

Affiliations

¹ Department of Dermatology, Hospital 12 de Octubre and Institute i+12, Medical School, Universidad Complutense, Madrid, Spain.
² Department of Pathology CIBERONC, Hospital 12 de Octubre and Institute i+12, Medical School, Universidad Complutense, Madrid, Spain.

PMID: 29797309
DOI: 10.1111/ajd.12836

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Antineoplastic Agents, Immunological / adverse effects*
Drug Eruptions / etiology*
Eosinophilia / chemically induced*
Fasciitis / chemically induced*
Humans
Lichen Sclerosus et Atrophicus / chemically induced*
Male
Middle Aged
Nivolumab / adverse effects*
Urinary Bladder Neoplasms / drug therapy*
Urinary Bladder Neoplasms / pathology

Substances

Antineoplastic Agents, Immunological
Nivolumab

Supplementary concepts

Eosinophilic Fasciitis